CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Cash Flows From Operating Activities:
Net earnings	$ 19,510	$ 20,171
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	7,319	6,864
Impairment of goodwill	0	0
Reserves for credit losses and sales returns	873	181
Provision for (recovery of) inventory allowances and inventory returns	(373)	698
Share-based compensation expense	1,736	874
Excess tax benefit from stock-based compensation	(965)	(233)
Tax benefit from stock-based compensation	0	438
Deferred taxes	471	(49)
Payments from lessees directly to lenders-operating leases	(2,978)	(4,039)
(Gain)/loss on disposal of property, equipment and operating lease equipment	(1,292)	(911)
Gain Loss On Sale Of Notes Receivable	(2,536)	0
Excess increase in cash value of life insurance	(94)	(73)
Other Noncash Income	256	0
Changes in:
Accounts receivable - net	(50,134)	(29,727)
Notes receivable	(1,130)	1,011
Inventories-net	(6,460)	(13,018)
Investment in direct financing and sale-type leases-net	(12,736)	15,830
Other assets	17,939	(9,771)
Accounts payable - equipment	(3,003)	(33,981)
Accounts payable - trade	15,780	1,219
Salaries and commissions payable, accrued expenses and other liabilities	(6,686)	11,883
Net cash used in operating activities	(24,503)	(32,633)
Cash Flows From Investing Activities:
Proceeds from sale of property, equipment and operating lease equipment	1,940	3,702
Purchases of property, equipment and operating lease equipment	(6,980)	(12,702)
Issuance of notes receivable	(39,676)	0
Repayments of notes receivable	14,422	0
Proceeds from sales of notes receivable	28,596	0
Premiums paid on life insurance	(93)	(105)
Cash used in acquisition, net of cash acquired	(3,514)	(1,761)
Net cash used in investing activities	(5,305)	(10,866)
Cash Flows From Financing Activities:
Borrowings of non-recourse and recourse notes payable	6,460	8,570
Repayments of non-recourse and recourse notes payable	(468)	(5,190)
Repurchase of common stock	(18,579)	(2,542)
Proceeds from issuance of capital stock through option exercise	586	2,902
Excess tax benefit from exercise of stock options	965	233
Net borrowings on floor plan facility	19,144	13,455
Net cash (used in) provided by financing activities	8,108	17,428
Effect of Exchange Rate Changes on Cash	(1)	(5)
Net (Decrease) Increase in Cash and Cash Equivalents	(21,701)	(26,076)
Cash and Cash Equivalents, End of Period	75,756	85,077
Cash and Cash Equivalents, End of Period	54,055	59,001
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	11	27
Cash paid for income taxes	7,544	11,814
Schedule of Non-Cash Investing and Financing Activities:
Purchase of property and equipment included in accounts payable	264	175
Purchase of operating lease equipment included in accounts payable	0	218
Principal payments from lessees directly to lenders	12,614	22,276
Contingent consideration	1,500	0
Vesting of share-based compensation	$ 1,887	$ 1,220